Facilitated By

San Antonio Medical Foundation

Entyvio (Vedolizumab) Long-Term Safety Study: An International Observational Prospective Cohort Study Comparing Vedolizumab To Other Biologic Agents In Patients With Ulcerative Colitis Or Crohn's Disease

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Principal Investigator(s)
Email for information
Funded by
Research Start Date

The Overall Study Sponsor has developed a study to assess the safety of vedolizumab versus other biologic agents in the real world setting. The participating physicians will be representative of the gastroenterologists who prescribe vedolizumab, or other biologic agents, per the local prescribing information in the participating countries.

Collaborative Project
Clinical Care
Infectious Disease
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.